Thomas J. Schall - 22 Mar 2024 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Thomas J. Schall
Issuer symbol
IMRX
Transactions as of
22 Mar 2024
Net transactions value
+$7,385
Form type
4
Filing time
25 Mar 2024, 16:03:33 UTC
Previous filing
12 Mar 2024
Next filing
13 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Purchase $7,385 +2,900 $2.55* 2,900 22 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.53 to $2.55. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.